Skip to main content
. 2017 Feb 24;8(12):20244–20251. doi: 10.18632/oncotarget.15666

Figure 2. The content of CRH, ACTH, ALD and AngII in plasma from SHR compared with WKY.

Figure 2

Note: compared with WKY, * P<0.05.